TNF and myeloid sarcoma: However, while it has been recently demonstrated that IFNβ-1a significantly suppressed plasma IL-6 and TNF-α levels [24], no data were available on cytokine gene polymorphism as a possible cause of the differential modulation of these cytokines and/or FLS in MS patients.